avatar

TRI MURTI ANDAYANI

Universitas Gadjah Mada S2 - Magister Farmasi Klinik SINTA ID : 5999671
1.914
SINTA Score Overall
480
SINTA Score 3Yr
1.914
Affil Score
480
Affil Score 3Yr
Latest number of publications
  Scopus Analysis  

Cost Analysis of Chronic Kidney Disease Patients in Indonesia
Q2 as Journal ClinicoEconomics and Outcomes Research
Author Order : 2 of 4     Creator : Sunariyanti E.
2023 0 cited
Translation, cultural adaptation, and psychometric validation of the Persian hypertension self-management questionnaire in South Sumatera, Indonesia
Q1 as Journal Pharmacy Practice
Author Order : 2 of 4     Creator : Rikmasari Y.
2023 0 cited
Cost Analysis of Therapy of Chronic Kidney Disease Inpatient In Indonesia
Q3 as Journal Research Journal of Pharmacy and Technology
Author Order : 2 of 4     Creator : Sunariyanti E.
2023 0 cited
Urban-Rural Difference in Adherence Treatment of Hypertensive Patients In South Sumatra Indonesia
no-Q as Conference Proceedin BIO Web of Conferences
Author Order : 2 of 4     Creator : Rikmasari Y.
2023 0 cited
Return on investment of health intervention among diabetic patient: A systematic review
no-Q as Conference Proceedin BIO Web of Conferences
Author Order : 4 of 4     Creator : Krisnadewi K.I.
2023 0 cited
The 5-Year Disease-Free Survival of Third Generation Aromatase Inhibitor for Postmenopausal Women with HR-positive HER2-negative Non-Metastatic Breast Cancer
Q3 as Journal International Journal of Hematology-Oncology and Stem Cell Research
Author Order : 2 of 4     Creator : Etikasari R.
2023 0 cited
Breast, cervical, and lung cancer: A comparison of real healthcare costs and INA-CBGs rates in the era of national health insurance
Q1 as Journal Pharmacy Practice
Author Order : 2 of 4     Creator : Yuliastuti F.
2023 1 cited
Comparison and validation of EuroQol-5 Dimension level and Short Form-6 Dimension in cataract patients
Q3 as Journal Pharmacy Education
Author Order : 1 of 3     Creator : Andayani T.M.
2022 0 cited
Health interventions and its impact on outcomes among diabetic patients: A systematic review
Q4 as Journal Pharmaceutical Sciences Asia
Author Order : 4 of 4     Creator : Krisnadewi K.I.
2022 0 cited
Cost-Effectiveness Analysis of Afatinib versus Gefitinib in Non-small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) Mutation in Indonesia: Observational studies with Retrospectives
Q3 as Journal Research Journal of Pharmacy and Technology
Author Order : 2 of 4     Creator : Sari S.
2022 0 cited
View more ...
Get More with SINTA Insight
Go to Insight

Summary

Article Quartile
Research Output
  Scopus GScholar WOS
Article 39 302 0
Citation 117 1593 0
Cited Document 19 170 0
H-Index 4 18
i10-Index 4 44
G-Index 1 1
Get More with SINTA Insight

Go to Insight